1. INDICATIONS AND USAGE Amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. Amiodarone hydrochloride tablet is an antiarrhythmic indicated for: Recurrent ventricular fibrillation ( 1 ). Recurrent hemodynamically unstable ventricular tachycardia ( 1 ).
zydus pharmaceuticals (usa) inc.
16. HOW SUPPLIED/STORAGE AND HANDLING
AMIODARONE HYDROCHLORIDE Tablets USP, 200 mg are white to off-white, round-shaped, flat beveled-edge, uncoated tablets with bisect on one side and other side is plain; one side of bisect is debossed with 'ZE' and other side is debossed with '65' and are supplied as follows: NDC 68382-227-06 in bottle of 30 tablets with child-resistant closure NDC 68382-227-14 in bottle of 60 tablets with child-resistant closure NDC 68382-227-05 in bottle of 500 tablets NDC 68382-227-10 in bottle of 1000 tablets NDC 68382-227-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets Storage: Store at 20Â° to 25Â°C (68Â° to 77Â°F) [See USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site